Offerings // AYTU BIOPHARMA, INC

AYTU offering history

Every offering-related filing in AYTU BIOPHARMA, INC’s recent SEC record — registrations (announced capacity) kept separate from pricing documents (executed sales). Reviewed 903 filings back to Jan 11, 2007.

Last executed offering
Apr 2, 2026
8-K — priced deal (shares or notes)
Last registration (announced)
Jun 6, 2025
S-1MEF — capacity, not a sale
Executed, last 12 months
1
424B pricings + 8-K 3.02 sales
Registered, last 12 months
0
S-1/S-3/F-series registrations
DateFilingWhat it means
Apr 2, 20268-KEXECUTEDUnregistered share sale disclosed (8-K item 3.02)
Jun 9, 2025424B4EXECUTEDFinal prospectus — offering priced (typical for IPOs and marketed share deals)
Jun 6, 2025S-1MEFREGISTEREDS-1MEF registration — capacity to sell shares, not a sale yet
Jun 5, 2025S-1/AREGISTEREDS-1/A registration — capacity to sell shares, not a sale yet
Jun 5, 2025EFFECTEFFECTIVESEC declared a registration effective — selling can begin
Jun 2, 2025S-1REGISTEREDS-1 registration — capacity to sell shares, not a sale yet
Oct 15, 2024EFFECTEFFECTIVESEC declared a registration effective — selling can begin
Oct 11, 2024S-3/AREGISTEREDS-3/A registration — capacity to sell shares, not a sale yet
Sep 26, 2024S-3REGISTEREDS-3 registration — capacity to sell shares, not a sale yet
Jun 12, 2023424B4EXECUTEDFinal prospectus — offering priced (typical for IPOs and marketed share deals)
Jun 9, 2023FWPMARKETINGFree-writing prospectus — offering being marketed
Jun 8, 2023EFFECTEFFECTIVESEC declared a registration effective — selling can begin
Jun 6, 2023FWPMARKETINGFree-writing prospectus — offering being marketed
Jun 5, 2023S-1/AREGISTEREDS-1/A registration — capacity to sell shares, not a sale yet
May 1, 2023S-1REGISTEREDS-1 registration — capacity to sell shares, not a sale yet
Nov 14, 2022424B5EXECUTEDShelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Aug 10, 2022424B5EXECUTEDShelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Aug 8, 2022424B5EXECUTEDShelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Jun 22, 2022EFFECTEFFECTIVESEC declared a registration effective — selling can begin
Jun 8, 2022S-3REGISTEREDS-3 registration — capacity to sell shares, not a sale yet
Mar 4, 2022424B2EXECUTEDProspectus supplement priced — shares or notes (large filers: often a bond deal)
Mar 3, 2022424B5EXECUTEDShelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Jan 31, 20228-KEXECUTEDUnregistered share sale disclosed (8-K item 3.02)
Jan 4, 20228-KEXECUTEDUnregistered share sale disclosed (8-K item 3.02)
Oct 7, 2021EFFECTEFFECTIVESEC declared a registration effective — selling can begin
Sep 28, 2021S-3REGISTEREDS-3 registration — capacity to sell shares, not a sale yet
Jun 7, 2021424B5EXECUTEDShelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Jun 7, 2021424B3UPDATEProspectus update — often a resale registration, not necessarily new capital
Feb 9, 2021424B3UPDATEProspectus update — often a resale registration, not necessarily new capital
Feb 9, 2021EFFECTEFFECTIVESEC declared a registration effective — selling can begin
Dec 14, 2020424B5EXECUTEDShelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Dec 11, 2020FWPMARKETINGFree-writing prospectus — offering being marketed
Dec 10, 2020424B5EXECUTEDShelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Dec 10, 2020FWPMARKETINGFree-writing prospectus — offering being marketed
Jul 2, 20208-KEXECUTEDUnregistered share sale disclosed (8-K item 3.02)
Jun 17, 2020EFFECTEFFECTIVESEC declared a registration effective — selling can begin
Jun 17, 2020EFFECTEFFECTIVESEC declared a registration effective — selling can begin
Jun 8, 2020S-3REGISTEREDS-3 registration — capacity to sell shares, not a sale yet
Apr 3, 2020424B3UPDATEProspectus update — often a resale registration, not necessarily new capital
Mar 20, 2020424B5EXECUTEDShelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
AYTU offering-related filings from SEC EDGAR, newest first (capped at 40). Each links to the original document.

Two honest limits. (1) A 424B takedown can price shares or notes— EDGAR’s metadata doesn’t say which, so open the document: large investment-grade filers use these mostly for bond deals (no dilution), small-caps mostly for shares. (2) At-the-market (ATM) programs sell shares gradually and individual sales are not separately filed — the visible footprint is the enabling shelf and its 424B5; actual ATM share counts surface later in the 10-Q/10-K share count. Educational information from public filings, not investment advice.

Is a shelf active now? →Do they need money? →Red flags →Full AYTU workspace →
AYTU offering FAQ

When did AYTU last execute an offering?

Per SEC filings, AYTU BIOPHARMA, INC's most recent priced offering document is a 8-K filed 2026-04-02. Note a 424B takedown can price shares or notes (debt) — the linked document says which.

When did AYTU last announce or register an offering?

The most recent registration is a S-1MEF filed 2025-06-06. A registration is capacity to sell shares — not a sale.

Does an offering always mean dilution?

Registered direct offerings and shelf takedowns issue new shares and dilute existing holders. Resale registrations (424B3/B7) let existing holders sell and do not create new shares. Secondary sales by insiders also do not dilute. Each row here is labeled with what it is.